Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medicinova Inc (MNOV)

Medicinova Inc (MNOV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 190,975
  • Shares Outstanding, K 48,968
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,850 K
  • 60-Month Beta 1.43
  • Price/Sales 45.33
  • Price/Cash Flow N/A
  • Price/Book 2.28
Trade MNOV with:

Options Overview Details

View History
  • Implied Volatility 129.93%
  • Historical Volatility 37.50%
  • IV Percentile 83%
  • IV Rank 44.29%
  • IV High 207.24% on 03/10/21
  • IV Low 68.47% on 08/13/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 36
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 676

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.09
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.80 +1.84%
on 09/20/21
4.32 -10.42%
on 09/02/21
+0.06 (+1.57%)
since 08/27/21
3-Month
3.33 +16.22%
on 08/16/21
4.34 -10.83%
on 06/28/21
-0.25 (-6.07%)
since 06/25/21
52-Week
3.33 +16.22%
on 08/16/21
10.81 -64.20%
on 03/10/21
-1.04 (-21.18%)
since 09/25/20

Most Recent Stories

More News
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 32nd International Symposium on ALS/MND

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that an abstract regarding...

MNOV : 3.89 (-0.26%)
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Ophthalmic Disease

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received...

MNOV : 3.89 (-0.26%)
MediciNova to Present at the Ladenburg Thalmann 2021 Virtual Healthcare Conference

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Yuichi Iwaki,...

MNOV : 3.89 (-0.26%)
MediciNova to Conduct Mouse Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it will conduct a mouse...

MNOV : 3.89 (-0.26%)
Thinking about buying stock in Torchlight Energy, Globalstar, MediciNova, Senseonics, or Clean Energy Fuels?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TRCH, GSAT, MNOV, SENS, and CLNE.

GSAT : 1.7050 (+1.49%)
SENS : 3.60 (+0.84%)
CLNE : 8.65 (+6.00%)
MNOV : 3.89 (-0.26%)
TRCH : 4.95 (+4.21%)
Thinking about buying stock in MediciNova, Torchlight Energy, Atossa Therapeutics, Globus Maritime, or ContextLogic?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MNOV, TRCH, ATOS, GLBS, and WISH.

MNOV : 3.89 (-0.26%)
WISH : 6.09 (+1.16%)
ATOS : 3.34 (-1.18%)
GLBS : 3.28 (+4.46%)
TRCH : 4.95 (+4.21%)
MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Nature's Translational Psychiatry Journal

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that positive results...

MNOV : 3.89 (-0.26%)
MediciNova to Participate in Maxim Group LLC Fireside Chat

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Yuichi Iwaki,...

MNOV : 3.89 (-0.26%)
MediciNova Initiates Sheep Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has initiated a...

MNOV : 3.89 (-0.26%)
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Europe

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received...

MNOV : 3.89 (-0.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

MEDICINOVA, INC. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. Through strategic alliances primarily with Japanesepharmaceutical companies,...

See More

Key Turning Points

3rd Resistance Point 4.05
2nd Resistance Point 4.02
1st Resistance Point 3.96
Last Price 3.89
1st Support Level 3.87
2nd Support Level 3.84
3rd Support Level 3.78

See More

52-Week High 10.81
Fibonacci 61.8% 7.95
Fibonacci 50% 7.07
Fibonacci 38.2% 6.19
Last Price 3.89
52-Week Low 3.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar